| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |